CONTEXT: Clusterin has been associated with several pathologies, including cardiovascular disease and neoplasias. However, little is known about its physiology and its association with metabolic and anthropometric parameters in humans. OBJECTIVE: The aim of the study was to examine whether circulating clusterin levels exhibit a day/night variation pattern and whether clusterin is associated with anthropometric and metabolic parameters. DESIGN: Study A was a frequent sampling study to evaluate potential periodicity in clusterin secretion. Study B was an observational study to evaluate the cross-sectional and prospective associations of clusterin with anthropometric and metabolic parameters. PARTICIPANTS: Study A participants were healthy males (n = 6) and females (n = 6), aged 22.3 ± 3.1 and 22.8 ± 3.4 yr, respectively. Study B participants were 186 healthy males aged 18.4 ± 0.14 yr. Ninety-one of the study B subjects were studied again 2 yr later and clusterin's associations with change of anthropometric and metabolic parameters were thus investigated prospectively. INTERVENTION: Samples in study A were collected every 15 min during an overnight admission, and subsequently pooled every hour. Samples in study B were collected during a screening visit. MAIN OUTCOME MEASURE: Circulating clusterin levels were measured. RESULTS: In study A, spectral domain and cosinor regression analysis failed to reveal any day/night variation pattern. In study B, clusterin was positively correlated with total and low-density lipoprotein cholesterol (r = 0.23, P = 0.002; and r = 0.20, P = 0.005). Baseline clusterin did not predict change of any anthropometric, biochemical, or metabolic parameters prospectively. CONCLUSIONS: We report for the first time that circulating clusterin does not have a day/night variation pattern in healthy young individuals. Clusterin levels are associated with total and low-density lipoprotein cholesterol cross-sectionally but do not predict short-term changes in metabolic parameters in healthy young males.
CONTEXT: Clusterin has been associated with several pathologies, including cardiovascular disease and neoplasias. However, little is known about its physiology and its association with metabolic and anthropometric parameters in humans. OBJECTIVE: The aim of the study was to examine whether circulating clusterin levels exhibit a day/night variation pattern and whether clusterin is associated with anthropometric and metabolic parameters. DESIGN: Study A was a frequent sampling study to evaluate potential periodicity in clusterin secretion. Study B was an observational study to evaluate the cross-sectional and prospective associations of clusterin with anthropometric and metabolic parameters. PARTICIPANTS: Study A participants were healthy males (n = 6) and females (n = 6), aged 22.3 ± 3.1 and 22.8 ± 3.4 yr, respectively. Study B participants were 186 healthy males aged 18.4 ± 0.14 yr. Ninety-one of the study B subjects were studied again 2 yr later and clusterin's associations with change of anthropometric and metabolic parameters were thus investigated prospectively. INTERVENTION: Samples in study A were collected every 15 min during an overnight admission, and subsequently pooled every hour. Samples in study B were collected during a screening visit. MAIN OUTCOME MEASURE: Circulating clusterin levels were measured. RESULTS: In study A, spectral domain and cosinor regression analysis failed to reveal any day/night variation pattern. In study B, clusterin was positively correlated with total and low-density lipoprotein cholesterol (r = 0.23, P = 0.002; and r = 0.20, P = 0.005). Baseline clusterin did not predict change of any anthropometric, biochemical, or metabolic parameters prospectively. CONCLUSIONS: We report for the first time that circulating clusterin does not have a day/night variation pattern in healthy young individuals. Clusterin levels are associated with total and low-density lipoprotein cholesterol cross-sectionally but do not predict short-term changes in metabolic parameters in healthy young males.
Authors: Ole-Petter R Hamnvik; Xiaowen Liu; Michael Petrou; Huizhi Gong; John P Chamberland; Esther H Kim; Costas A Christophi; Stefanos N Kales; David C Christiani; Christos S Mantzoros Journal: Metabolism Date: 2010-11-05 Impact factor: 8.694
Authors: H V de Silva; W D Stuart; Y B Park; S J Mao; C M Gil; J R Wetterau; S J Busch; J A Harmony Journal: J Biol Chem Date: 1990-08-25 Impact factor: 5.157
Authors: Jean L Chan; Kathleen Heist; Alex M DePaoli; Johannes D Veldhuis; Christos S Mantzoros Journal: J Clin Invest Date: 2003-05 Impact factor: 14.808
Authors: H V de Silva; W D Stuart; C R Duvic; J R Wetterau; M J Ray; D G Ferguson; H W Albers; W R Smith; J A Harmony Journal: J Biol Chem Date: 1990-08-05 Impact factor: 5.157
Authors: Jean L Chan; Giuseppe Matarese; Greeshma K Shetty; Patricia Raciti; Iosif Kelesidis; Daniela Aufiero; Veronica De Rosa; Francesco Perna; Silvia Fontana; Christos S Mantzoros Journal: Proc Natl Acad Sci U S A Date: 2006-05-19 Impact factor: 11.205
Authors: Ji A Seo; Min-Cheol Kang; Theodore P Ciaraldi; Sang Soo Kim; Kyong Soo Park; Charles Choe; Won Min Hwang; Dong Mee Lim; Olivia Farr; Christos Mantzoros; Robert R Henry; Young-Bum Kim Journal: Metabolism Date: 2017-10-03 Impact factor: 8.694
Authors: Yun Kyung Jeon; Sang Soo Kim; Jong Ho Kim; Hyun Jeong Kim; Hyun Jun Kim; Jang Jun Park; Yuen Suk Cho; So Hee Joung; Ji Ryang Kim; Bo Hyun Kim; Sang Heon Song; In Joo Kim; Yong Ki Kim; Young Bum Kim Journal: Diabetes Metab J Date: 2020-02 Impact factor: 5.376